SG3 Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,500
Closed -$150K 74
2022
Q4
$150K Sell
5,500
-100
-2% -$4.58K 0.02% 171
2022
Q3
$301K Buy
+5,600
New +$288K 0.04% 175
2022
Q2
Sell
-1,800
Closed -$119K 556
2022
Q1
$119K Sell
1,800
-22,700
-93% -$1.55M ﹤0.01% 824
2021
Q4
$2.45M Buy
+24,500
New +$2.53M 0.05% 300

Other funds holding GH

SG3 Management's GH Position: Q4 2022 in Review

SG3 Management sold out of Guardant Health (GH) in Q4 2022, closing a stake of 7,000 shares — an estimated $320K sold.

SG3 Management first reported a position in GH in Q4 2021 and held it in 2 quarters. The position peaked at $800K in Q4 2021. 292 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • SG3 Management reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • SG3 Management sold 7,000 Guardant Health shares in Q4 2022, an estimated $320K.
  • SG3 Management first reported a position in Guardant Health in Q4 2021 and held it in 2 quarters.
  • SG3 Management's Guardant Health position peaked at $800K in Q4 2021.
  • 292 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on SG3 Management's 13F filing for Q4 2022, filed 14 Feb 2023.